{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:27:01Z","timestamp":1791188821536,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:00:00Z","timestamp":1425427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003546","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T19:00:19Z","timestamp":1425495619000},"page":"e0003546","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Lu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meleana","family":"Hinchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1469-0691.2004.01046.x","article-title":"Cutaneous leishmaniasis: an increasing threat for travellers","volume":"11","author":"S Antinori","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1051\/vetres\/2009021","article-title":"Perpetuation of Leishmania: some novel insight into elegant developmental programs","volume":"40","author":"G Milon","year":"2009","journal-title":"Vet Res"},{"key":"ref4","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"A Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref5","first-page":"942","article-title":"Progress towards a Leishmania vaccine","volume":"27","author":"KS Tabbara","year":"2006","journal-title":"Saudi Med J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"A Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.16.4.637-646.2003","article-title":"Role of Toll-like receptors in pathogen recognition","volume":"16","author":"S Janssens","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"I Arevalo","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"S Buates","year":"1999","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0264-410X(02)00550-9","article-title":"Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3&apos; sequence modifications","volume":"21","author":"S Zimmermann","year":"2003","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","article-title":"CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis","volume":"160","author":"S Zimmermann","year":"1998","journal-title":"Journal of immunology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/IAI.73.8.4948-4954.2005","article-title":"Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D\/A oligodeoxynucleotides expressing CpG motifs","volume":"73","author":"B Flynn","year":"2005","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/eji.200323671","article-title":"Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation","volume":"33","author":"N Datta","year":"2003","journal-title":"Eur J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1128\/IAI.71.9.5121-5129.2003","article-title":"Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability","volume":"71","author":"S Mendez","year":"2003","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1002\/eji.200636472","article-title":"Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides","volume":"36","author":"W Wu","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/CVI.00249-09","article-title":"Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation","volume":"16","author":"EM Laabs","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/eji.201040484","article-title":"A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL\/6 mice","volume":"40","author":"W Wu","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pt.2009.05.004","article-title":"The role of host genetics in leishmaniasis","volume":"25","author":"A Sakthianandeswaren","year":"2009","journal-title":"Trends Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1574-695X.2007.00311.x","article-title":"Immune response to leishmania: paradox rather than paradigm","volume":"51","author":"P Tripathi","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1016\/j.vaccine.2009.05.027","article-title":"In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli","volume":"27","author":"S Liang","year":"2009","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"17481","DOI":"10.1073\/pnas.0903313106","article-title":"Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides","volume":"106","author":"S Gallorini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1615\/CritRevImmunol.v30.i2.60","article-title":"Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant","volume":"30","author":"AU Bielinska","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"GF Spath","year":"2001","journal-title":"Exp Parasitol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge","volume":"166","author":"S Mendez","year":"2001","journal-title":"Journal of immunology"},{"key":"ref25","first-page":"Unit 16","article-title":"Choosing and preparing antigen-presenting cells","volume":"Chapter 16","author":"CV Harding","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00160-9","article-title":"Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2","volume":"130","author":"I Becker","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/eji.200324128","article-title":"MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling","volume":"33","author":"MJ de Veer","year":"2003","journal-title":"Eur J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1017\/S0031182009990473","article-title":"The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs)","volume":"136","author":"G Kavoosi","year":"2009","journal-title":"Parasitology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.4049\/jimmunol.0713598","article-title":"IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice","volume":"182","author":"S Lopez Kostka","year":"2009","journal-title":"Journal of immunology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2010.08.014","article-title":"Innate immunity and Leishmania vaccination strategies","volume":"29","author":"R Birnbaum","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20030645","article-title":"Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice","volume":"198","author":"JA Shah","year":"2003","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection","volume":"195","author":"EG Rhee","year":"2002","journal-title":"J Exp Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1084\/jem.188.10.1941","article-title":"Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis","volume":"188","author":"Y Belkaid","year":"1998","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.165.2.969","article-title":"A natural model of Leishmania major infection reveals a prolonged &quot;silent&quot; phase of parasite amplification in the skin before the onset of lesion formation and immunity","volume":"165","author":"Y Belkaid","year":"2000","journal-title":"Journal of immunology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20040298","article-title":"Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity","volume":"200","author":"S Mendez","year":"2004","journal-title":"J Exp Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Y Belkaid","year":"2002","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/sji.12105","article-title":"TLR2 and TLR4 in cutaneous leishmaniasis caused by Leishmania major","volume":"78","author":"S Tolouei","year":"2013","journal-title":"Scandinavian journal of immunology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1128\/IAI.70.12.6638-6645.2002","article-title":"Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB\/c and C57BL\/6 mice","volume":"70","author":"T Liu","year":"2002","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"C Pirmez","year":"1993","journal-title":"The Journal of clinical investigation"},{"key":"ref40","article-title":"Pegylated Bisacycloxypropylcysteine, a Diacylated Lipopeptide Ligand of TLR6, Plays a Host-Protective Role against Experimental Leishmania major Infection","author":"SP Pandey","year":"2014","journal-title":"Journal of immunology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3347\/kjp.2013.51.1.69","article-title":"The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB\/c mice","volume":"51","author":"H Mahmoudzadeh-Niknam","year":"2013","journal-title":"The Korean journal of parasitology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1159194","article-title":"In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies","volume":"321","author":"NC Peters","year":"2008","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.4049\/jimmunol.165.5.2628","article-title":"An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB\/c mice infected with Leishmania major","volume":"165","author":"F Tacchini-Cottier","year":"2000","journal-title":"Journal of immunology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e13815","DOI":"10.1371\/journal.pone.0013815","article-title":"Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages","volume":"5","author":"EV de Souza Carmo","year":"2010","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/pim.12078","article-title":"Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB\/c mice","volume":"36","author":"LM Sousa","year":"2014","journal-title":"Parasite immunology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.4049\/jimmunol.0803720","article-title":"Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection","volume":"183","author":"FO Novais","year":"2009","journal-title":"Journal of immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1189\/jlb.0706440","article-title":"Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection","volume":"82","author":"M Charmoy","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref48","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"MG Pitta","year":"2009","journal-title":"The Journal of clinical investigation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni.2797","article-title":"Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2","volume":"15","author":"PR Taylor","year":"2014","journal-title":"Nature immunology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1371\/journal.pntd.0001204","article-title":"TLR1\/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)","volume":"5","author":"A Jayakumar","year":"2011","journal-title":"PLoS neglected tropical diseases"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.4049\/jimmunol.180.12.8299","article-title":"The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma","volume":"180","author":"N Pakpour","year":"2008","journal-title":"Journal of immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.160197797","article-title":"The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory\/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge","volume":"97","author":"L Stobie","year":"2000","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T15:44:01Z","timestamp":1691509441000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003546"}},"subtitle":[],"editor":[{"given":"Mary Ann","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,4]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003546","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,4]]}}}